H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 14.6% of adults in Kansas City have diagnosed diabetes — 2.6 points above the U.S. 12% figure. Census population 156,607. Kansas Medicare wound biologics: WPS Government Health Administrators (J5). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Kansas City clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Kansas City storefront.
Joint Preservation Therapy Solutions in Kansas City, KS for clinics & physicians. Joint preservation thera… Compliance support & pricing — contact Hawk Medical.
Adult arthritis here is 23.3% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. CDC PLACES (2023, crude) estimates 14.6% of adults in Kansas City have diagnosed diabetes — 2.6 points above the U.S. 12% figure. Together those PLACES numbers are why a city under 250k still needs separate PRP and CTP protocols. joint preservation therapy inventory is national; utilization is J5-local.
National Joint Preservation Therapy Solutions notes (how the product actually works)J5 reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Kansas City is 14.6% or not. PLACES is planning data. The LCD is the claim.
If you already buy joint preservation therapy elsewhere, use this page as a check: homologous-use language, current WPS Government Health Administrators article IDs, and PLACES 14.6% diabetes as the epidemiologic floor. If that is how you already practice, the catalog will fit.
CDC PLACES (2023, crude prevalence) estimates 14.6% of adults — 2.6 points above the U.S. 12% figure. Obesity is 41.2%; arthritis is 23.3%. That is place-level BRFSS modeling, not a clinic census and not a Kansas City trial.
Joe Bradley, Founder & CEO of Hawk Medical LLC, is an active clinical practice owner. These programmatic pages are distribution resources for providers, reviewed against the same HCT/P and wound-care portfolio used in that practice. They are not patient treatment advice.
Yes. Tissue products come from FDA-registered banks with donor screening and lot traceability. Your receiving SOP should file IFU, lot, and indication with the chart. That packet is what J5 reviewers and surveyors expect — not a brochure.
Kansas is J5. A sister clinic in another state may be a different contractor with different CTP articles. Do not assume one utilization policy ports. We map both if you operate across MACs.
Ask for the IFU, the lot-traceability packet, and the WPS Government Health Administrators article IDs for the codes you actually bill. If the sales sheet cannot produce those, do not put it in a Kansas City fridge. That is how an account with us starts.
Contact us to learn how Hawk Medical supports practices in Kansas City, KS.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Kansas City is J5 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Kansas City — 2.6 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Kansas Part B wound biologics follow this contractor (siblings: IA, MO, NE). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Kansas City. Useful for joint-program math; still needs a diagnosis and privileging.
No Kansas City storefront. Joe Bradley is an active practice owner. joint preservation therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.